By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Gen-Probe announced after the close of the market on Tuesday a 2 percent decline in fourth-quarter revenues as product revenues shrank 3 percent.

The company also announced a $150 million share buyback program.

For the three months ended Dec. 31, 2010, the San Diego molecular diagnostics firm posted overall revenues of $136.7 million, down from $138.9 million a year ago, and short of consensus analyst estimates of $137.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.